Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.

Effects of Intermittent Fasting on Liver Steatosis and Fibrosis, Serum FGF-21 and Autophagy Markers in Metabolic Dysfunction-Associated Fatty Liver Disease: A Randomized Controlled Trial

Open access
Ozlu Karahan, Tugce, Yilmaz Akyuz, Elvan, Yilmaz Karadag, Demet, Yilmaz, Yusuf, Eren, Fatih · 2025 · Life

Abstract

Background: This randomized controlled study sought to determine the effect of intermittent fasting on anthropometric measurements, fibroblast growth factor (FGF)-21, and autophagy markers, as well as on hepatic steatosis and fibrosis levels in overweight or obese patients with metabolic dysfunction-associated fatty liver disease (MAFLD). Methods: Patients were randomly assigned into two groups: received a dietary treatment involving 22–25 kcal/kg/day of energy for 8 weeks and followed the same dietary intervention and a 16:8 pattern. The extent of hepatic steatosis and fibrosis was determined using transient elastography on a FibroScan® device. The controlled attenuation parameter (CAP) and liver stiffness measurement (LSM), determined by transient elastography, reflect hepatic steatosis and fibrosis, respectively. In duplicate, serum levels of FGF-21, Beclin-1, and ATG-5 were determined using enzyme-linked immunosorbent assay. Results: The study included 48 patients with a mean age of 48.2 ± 1.4 years (27 female and 21 male). Improvements in anthropometric measurement and CAP and LSM levels and a decrease in serum FGF-21 levels were found in both groups (p < 0.05). Changes in the CAP and FGF-21 levels were higher in the energy + time-restricted diet group (p < 0.05). Autophagy-related protein (ATG)-5 levels increased only in the energy + time-restricted diet group [(0.74 (0.46–1.29) ng/mL vs. 0.95 (0.73–1.32) ng/mL, p = 0.03]. Conclusions: Intermittent fasting was potentially practical in the management of MAFLD. In particular, changes in FGF-21 and ATG-5 levels indicate the potential of intermittent fasting to regulate metabolic processes and autophagy. However, methodological limitations should be taken into consideration when interpreting the study results.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/life15050696

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Design of the study.
Figure 1 Design of the study.CC BY · PubMed Central
Figure 2 Flowchart of the study.
Figure 2 Flowchart of the study.CC BY · PubMed Central
Figure 3 Analysis of biochemical and Fibroscan measurements after intervention. Data are expressed as medians (95% confidence interval for median). Wilcoxon analysis was performed. Statistical significance, * p < 0.05, significant p values are indicated in bold. CAP: controlled attenuation parameter; LSM: liver stiffness measurement; ATG-5: autophagy-related protein-5; FGF-21: fibroblast growth factor-21. The blue color indicates T0 time, and the orange color indicates T8 time.
Figure 3 Analysis of biochemical and Fibroscan measurements after intervention. Data are expressed as medians (95% confidence interval for median). Wilcoxon analysis was performed. Statistical significance, * p < 0.05, significant p values are indicated in bold. CAP: controlled attenuation parameter; LSM: liver stiffness measurement; ATG-5: autophagy-related protein-5; FGF-21: fibroblast growth factor-21. The blue color indicates T0 time, and the orange color indicates T8 time.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 69 references

Cited by

See all 9

Metadata

Authors
Ozlu Karahan, T., Yilmaz Akyuz, E., Yilmaz Karadag, D., Yilmaz, Y., & Eren, F.
Affiliations
  • Department of Nutrition and Dietetics, Faculty of Health Sciences, Istanbul Bilgi University, Istanbul 34440, Turkey
  • Department of Nutrition and Dietetics, Hamidiye Faculty of Health Sciences, University of Health Sciences, Istanbul 34668, Turkey
  • Institute of Gastroenterology, Marmara University, Istanbul 34854, Turkey
  • Recep Tayyip Erdoğan University (TR)
Corresponding author
Eren, Fatih
Venue
Life
Publisher
MDPI AG
Published
2025-04-25
Volume
15
Issue
5
Pages
696
ISSN
2075-1729 (ISSN-L)
OpenAlex
W4409781467
Cited by
9
References
69
Citations by year
2026: 8 · 2025: 1
FWCI
6.20
Type
journal article
Language
en
Open access
Locations
  • Life (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Health Institutes of Türkiye (TUSEB) (24172, 02025002003275)
  • Recep Tayyip Erdoğan University Development Foundation (24172, 02025002003275)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
Keywords
intermittent fasting, non-alcoholic fatty liver disease, hepatic steatosis, liver fibrosis, FGF21, autophagy, ATG5, Beclin-1, time-restricted eating, hypocaloric diet, obesity, transient elastography, controlled attenuation parameter, liver stiffness measurement

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of Intermittent Fasting on Liver Steatosis and Fibrosis, Serum FGF-21 and Autophagy Markers in Metabolic Dysfunction-Associated Fatty Liver Disease: A Randomized Controlled Trial. https://app.cochat.ai/papers/10.3390/life15050696
The paper
Ozlu Karahan, T., Yilmaz Akyuz, E., Yilmaz Karadag, D., Yilmaz, Y., & Eren, F. (2025). Effects of Intermittent Fasting on Liver Steatosis and Fibrosis, Serum FGF-21 and Autophagy Markers in Metabolic Dysfunction-Associated Fatty Liver Disease: A Randomized Controlled Trial. Life. https://doi.org/10.3390/life15050696

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.